AI assistant
Sending…
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Nov 15, 2021
30320_dirs_2021-11-15_0b06b4b2-f192-4741-b3ae-bbab83ef4069.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-11-15
Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Common Stock | M | 3083 | $53.42 | Acquired | 3213 | Direct |
| 2021-11-15 | Common Stock | S | 3083 | $203.45 | Disposed | 130 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | Stock Options | $53.42 | M | 3083 | Disposed | 2022-12-31 | Common Stock (3083) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 166 | Indirect |
| Common Stock | 651549 | Indirect |
Footnotes
F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
More from UNITED THERAPEUTICS Corp
Regulatory Filings
2026
Jun 2
Earnings Release
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26